Article Details
Retrieved on: 2024-05-20 20:51:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Investors might want to bet on Galena Biopharma, Inc. (NASDAQ: SLS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in ...
Article found on: uk.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here